Equities research analysts predict that athenahealth, Inc. (NASDAQ:ATHN) will post sales of $298.48 million for the current quarter, according to Zacks Investment Research. Twelve analysts have issued estimates for athenahealth’s earnings, with estimates ranging from $291.00 million to $306.25 million. athenahealth posted sales of $261.94 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 13.9%. The business is expected to issue its next earnings results on Thursday, July 20th.

On average, analysts expect that athenahealth will report full year sales of $298.48 million for the current year, with estimates ranging from $1.20 billion to $1.32 billion. For the next fiscal year, analysts expect that the company will post sales of $1.39 billion per share, with estimates ranging from $1.34 billion to $1.45 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover athenahealth.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, April 27th. The health services provider reported $0.10 EPS for the quarter, missing the Zacks’ consensus estimate of $0.11 by $0.01. The business had revenue of $285.40 million for the quarter, compared to the consensus estimate of $296.49 million. athenahealth had a net margin of 1.84% and a return on equity of 5.93%. athenahealth’s revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.34 earnings per share.

Several equities research analysts have recently issued reports on ATHN shares. Cantor Fitzgerald reissued a “buy” rating and set a $118.00 target price (down from $135.00) on shares of athenahealth in a research note on Thursday, April 27th. Piper Jaffray Companies reissued an “overweight” rating and set a $160.00 target price on shares of athenahealth in a research note on Tuesday, April 4th. Citigroup Inc. reissued a “buy” rating and set a $163.00 target price (up from $128.00) on shares of athenahealth in a research note on Monday, June 5th. Evercore ISI reissued an “outperform” rating and set a $147.00 target price (up from $118.00) on shares of athenahealth in a research note on Friday, May 19th. Finally, Jefferies Group LLC reissued a “sell” rating and set a $95.00 target price on shares of athenahealth in a research note on Friday, March 24th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have issued a buy rating to the company’s stock. athenahealth has a consensus rating of “Hold” and an average target price of $138.74.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/06/21/zacks-brokerages-expect-athenahealth-inc-athn-will-announce-quarterly-sales-of-298-48-million.html.

In other athenahealth news, CEO Jonathan Bush sold 8,000 shares of the stock in a transaction dated Tuesday, April 25th. The shares were sold at an average price of $120.00, for a total value of $960,000.00. Following the completion of the sale, the chief executive officer now owns 319,807 shares in the company, valued at approximately $38,376,840. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Jonathan D. Porter sold 300 shares of the stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $142.27, for a total transaction of $42,681.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 20,583 shares of company stock valued at $2,612,204. 3.20% of the stock is owned by insiders.

Hedge funds have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. purchased a new stake in shares of athenahealth during the fourth quarter worth about $118,000. State Board of Administration of Florida Retirement System increased its stake in shares of athenahealth by 1.9% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 57,608 shares of the health services provider’s stock worth $6,059,000 after buying an additional 1,068 shares in the last quarter. Comerica Bank purchased a new stake in shares of athenahealth during the fourth quarter worth about $299,000. Baird Financial Group Inc. increased its stake in shares of athenahealth by 7.8% in the fourth quarter. Baird Financial Group Inc. now owns 11,713 shares of the health services provider’s stock worth $1,232,000 after buying an additional 851 shares in the last quarter. Finally, Trexquant Investment LP purchased a new stake in shares of athenahealth during the fourth quarter worth about $593,000.

Shares of athenahealth (NASDAQ:ATHN) opened at 145.63 on Wednesday. The firm’s 50-day moving average price is $127.14 and its 200-day moving average price is $116.94. athenahealth has a 12-month low of $90.11 and a 12-month high of $146.75. The company has a market capitalization of $5.80 billion, a PE ratio of 286.67 and a beta of 1.81.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Get a free copy of the Zacks research report on athenahealth (ATHN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.